NCT00018382

Data

{
  "briefSummary": "This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.",
  "completionDate": "2003-03",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": null,
  "enrollmentType": null,
  "nctId": "NCT00018382",
  "phase": "PHASE2",
  "sponsorId": "us-department-of-veterans-affairs",
  "startDate": "1999-10",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach",
  "url": "https://clinicaltrials.gov/study/NCT00018382"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version